articles, women's health, obstetrics, gynecology, infertility, pregnancy, hysterectomy, fibroids, and more

 

Print this page
OBGYN.net Advertisement
Breast Care
Disease information overseen by physicians from the nation's top hospitals

 

 

 
Veritas Medicine

   Breast Care

Scientists and research groups are working to improve the way breast cancer is treated. Current treatments have helped many women survive breast cancer, but they are not always effective and often have unpleasant side effects. Some research is directed at finding better ways to use currently available drugs. For example, by using different combinations, or by adjusting the doses used, current drugs may be more effective in treating breast cancer and may have fewer side effects. Other research is focused on developing new drugs for the treatment of breast cancer

     Endometriosis

Current treatment for endometriosis may involve medications or surgical procedures.  For many women these therapies provide significant relief.  However, these therapies can have side effects and may not work for everyone.  Therefore, researchers are investigating new and improved treatments strategies.  Many involve enhanced hormonal agents and some are related to recent insights into the immune system and its role in endometriosis.

     Infertility

Historically, interest in the diagnosis and treatment of infertility has lagged behind that of many other fields in medicine.  Moreover, advances in treating male infertility have been outpaced by those in female infertility.  As a result, many of the standard treatments for infertility, particularly male factor infertility, are either incompletely understood or incompletely tested.  Many experimental therapies are therefore extensions of standard therapies.  This is true for all three types of treatment for male factor infertility: pharmacologic, surgical, and those involving assisted reproductive technologies (ART).

     Pregnancy and Birth

Unfortunately, there has been limited progress in the treatment of recurrent pregnancy loss (RPL).  This is for several reasons.  Scientists still have a poor understanding of the causes of RPL.  Inconsistent definition of the condition has made it difficult to compare and evaluate clinical trials for RPL.  The clinical trials themselves can be substandard.  Finally, data indicate that most RPL patients will, in fact, have a successful pregnancy the next time they conceive.  This makes demonstrating treatment success difficult, requiring very large study populations for appropriate statistical analysis.